Filing Analysis
Vuzix Corporation issued an 8-K to announce its financial results for the quarterly period ended June 30, 2026. The filing serves as a formal announcement of the release of the company's latest earnings press release.
📋 Key Facts
- Report date: August 13, 2026
- Filing date: August 17, 2026
- Reporting period ended: June 30, 2026
- The filing includes a press release (Exhibit 99.1) detailing financial results.
Vuzix Corp entered into a new 'at the market' (ATM) sales agreement with Jefferies LLC to facilitate the sale of common stock up to an aggregate price of $100,000,000. This agreement replaces a previous ATM program established in February 2024.
🚩 Red Flags
- Potential significant dilution for existing shareholders due to the $100M ATM offering capacity.
- ATM offerings are often used by micro-cap companies to raise immediate working capital, which can signal liquidity needs.
📋 Key Facts
- Entered into Open Market Sales Agreement (SM) with Jefferies LLC on August 14, 2026.
- Aggregate offering price of up to $100,000,000 in common shares.
- Jefferies will act as the sales agent using 'at the market' methods under Rule 415(a)(4).
- Company will pay Jefferies a commission of 3.0% of aggregate gross proceeds.
- The program replaces the prior Sales Agreement dated February 9, 2024.
Vuzix Corporation reported the results of its annual meeting of stockholders held on June 16, 2026. The meeting resulted in the election of five directors, the ratification of Withum Smith+Brown, PC as the independent auditor, and the advisory approval of executive compensation.
📋 Key Facts
- Annual meeting of stockholders held on June 16, 2026.
- Elected directors: Paul Travers, Grant Russell, Timothy Harned, Paula Whitten-Doolin, and Alasdair MacKinnon.
- Withum Smith+Brown, PC ratified as the independent registered public accounting firm for 2026.
- Executive compensation was approved on an advisory basis with 21,461,045 votes for and 5,191,050 votes against.
Vuzix Corporation reported its financial results for the first quarter ended March 31, 2026. The filing serves as a formal notice of the earnings press release issued on May 14, 2026.
📋 Key Facts
- Financial results cover the period ended March 31, 2026
- Press release was issued on May 14, 2026
- The report was filed under Item 2.02 (Results of Operations and Financial Condition)
- Grant Russell, CFO, signed the filing on May 15, 2026
Vuzix Corporation granted a total of 670,436 Restricted Stock Units (RSUs) to its CEO and CFO as part of their compensatory arrangements. The grants are split between time-based and performance-based vesting schedules extending through December 2028.
📋 Key Facts
- CEO Paul Travers was granted 477,178 RSUs on April 29, 2026.
- CFO Grant Russell was granted 193,258 RSUs on April 29, 2026.
- 50% of the RSUs are time-based, vesting in three equal annual installments starting December 15, 2026.
- 50% of the RSUs are performance-based, with a potential payout increase up to 150% of the target amount based on achievements through December 31, 2028.
- The grants were issued under the Company's existing 2023 Equity Incentive Plan.
Vuzix Corporation announced the departure of Dr. Chris Parkinson, President of the Enterprise Solutions business unit, effective April 22, 2026. The departure was by mutual agreement and resulted in the forfeiture of 1,000,000 unvested performance stock units.
🚩 Red Flags
- Departure of a key business unit leader (Enterprise Solutions).
- Forfeiture of a substantial amount (1,000,000) of performance stock units, which may imply that performance hurdles were unlikely to be met.
📋 Key Facts
- Dr. Chris Parkinson's employment as President of Enterprise Solutions ended on April 22, 2026.
- The departure was described as being by "mutual agreement."
- 75,000 previously unvested shares of restricted common stock vested in connection with the departure.
- Dr. Parkinson forfeited 1,000,000 unvested performance stock units (PSUs).
Vuzix Corporation announced its financial results for the fiscal year ended December 31, 2025, via a press release issued on March 12, 2026.
📋 Key Facts
- The company reported financial results for the period ended December 31, 2025.
- The report was filed under Item 2.02 (Results of Operations and Financial Condition).
- The announcement was made on March 12, 2026, and the 8-K was filed on March 13, 2026.
- Exhibit 99.1 contains the full press release regarding the financial results.
Vuzix Corporation filed an 8-K to announce the release of its financial results for the period ended September 30, 2025. The filing serves as a formal notice that earnings data is being made public via an attached press release.
📋 Key Facts
- Reporting date: November 13, 2025
- Filing date: November 14, 2025
- Subject matter: Financial results for the period ended September 30, 2025
- Exhibit 99.1 contains the full press release of financial results
Vuzix Corporation completed the third and final tranche of a securities purchase agreement with Quanta Computer Inc. on September 19, 2025. This transaction involved the sale of Series B Preferred Stock to an institutional partner.
🚩 Red Flags
- Potential future dilution: The conversion ratio of 10:1 implies that the closing of this tranche could result in the issuance of up to 2,302,420 shares of common stock upon conversion.
📋 Key Facts
- Completed closing of the third and final tranche of a securities purchase agreement dated September 3, 2024.
- Counterparty: Quanta Computer Inc.
- Shares sold: 230,242 shares of Series B Preferred Stock.
- Conversion ratio: Each share of Series B is convertible into 10 shares of common stock.
- Purchase price: $21.716 per share (of preferred stock).
- Transaction conducted under Section 4(a)(2) exemption from registration.
Vuzix Corporation announced the appointment of Dr. Chris Parkinson as the new President of its Enterprise Solutions business unit. The filing details his compensation package, which includes a base salary and significant equity incentives tied to performance targets.
📋 Key Facts
- Dr. Chris Parkinson appointed as President of Enterprise Solutions business unit on September 3, 2025.
- Annual base salary set at $360,000.
- Compensation includes 150,000 Restricted Stock Awards (RSAs) vesting quarterly over 12 months.
- Compensation includes 1,000,000 Performance Stock Units (PSUs) subject to revenue and EBITDA targets for the Enterprise Solutions unit through December 31, 2028.
- Severance provision: 12 months' salary if terminated without cause.
Vuzix Corporation has replaced its independent auditor, Freed Maxick P.C., with Withum Smith+Brown, PC, effective August 22, 2025. The change follows a prior-year going concern warning and the remediation of a material weakness in internal controls.
🚩 Red Flags
- Historical 'going concern' language in FY2023 audit report.
- History of material weakness in internal control over financial reporting (though reported as remediated).
- Auditor change often requires heightened scrutiny, even when the reason is personnel movement.
📋 Key Facts
- Effective date of auditor change: August 22, 2025.
- Outgoing Auditor: Freed Maxick P.C. (FM).
- Incoming Auditor: Withum Smith+Brown, PC (Withum).
- Reason for departure: FM personnel joined the new firm (Withum).
- The FY2023 audit included an explanatory paragraph regarding substantial doubt about the company's ability to continue as a going concern.
- A material weakness in internal control over financial reporting was disclosed in the 2023 10-K but was remediated during 2024.
Vuzix Corporation filed an 8-K to announce the release of its financial results for the quarterly period ended June 30, 2025. The filing serves as a formal notification that earnings data is being made public via an attached press release.
📋 Key Facts
- Report date: August 14, 2025
- Reporting period end date: June 30, 2025
- The filing includes Exhibit 99.1 containing the official press release of financial results.
- Signed by Grant Russell, Chief Financial Officer.
Vuzix Corporation announced the election of Alasdair MacKinnon to its Board of Directors and several committees, as well as the passing of long-standing board member Edward Kay.
🚩 Red Flags
- Loss of a long-term board member (Edward Kay) who served for over 9 years.
📋 Key Facts
- Alasdair MacKinnon elected to the Board of Directors on August 5, 2025.
- Mr. MacKinnon will serve on the Nominating, Audit (as Chairperson), and Compensation committees.
- Edward Kay passed away on July 23, 2025; he had served on the board since April 2016.
Vuzix Corporation held its annual meeting of stockholders on June 17, 2025. The filing reports the results of shareholder votes regarding director elections, auditor ratification, executive compensation, and an increase in authorized shares.
🚩 Red Flags
- Concurrent cancellation of 5,089,500 existing options alongside a new RSU grant may indicate a restructuring of equity incentives or dilution management strategy.
📋 Key Facts
- Annual meeting held on June 17, 2025.
- Five directors (Paul Travers, Grant Russell, Edward Kay, Timothy Harned, and Paula Whitten-Doolin) were elected to serve until the next annual meeting.
- Freed Maxick P.C. was ratified as the independent registered public accounting firm for 2025.
- Shareholders approved an amendment to increase authorized shares of common stock to 200,000,000.
- Shareholders approved the grant of 594,056 Restricted Stock Units (RSUs) and the concurrent cancellation of 5,089,500 previously granted options.
Vuzix Corporation completed the second tranche of a securities purchase agreement with Quanta Computer Inc. on June 13, 2025. The transaction involved the sale of Series B Preferred Stock for approximately $5 million in gross proceeds.
🚩 Red Flags
- Significant potential dilution due to the 10:1 conversion ratio of Series B Preferred Stock into common stock (approx. 1.89 million common shares).
📋 Key Facts
- Completed closing of the second tranche of an SPA dated September 3, 2024.
- Counterparty: Quanta Computer Inc.
- Shares sold: 189,717 shares of Series B Preferred Stock.
- Conversion ratio: Each share of Series B is convertible into 10 shares of common stock.
- Purchase price per preferred share: $26.35.
- Gross proceeds received: $4,999,980.
Vuzix Corporation filed an 8-K to announce the release of its financial results for the quarterly period ended March 31, 2025. The filing serves as a formal notification that earnings data is being made public via an attached press release.
📋 Key Facts
- Reporting date: May 12, 2025
- Filing date: May 14, 2025
- Period covered: Quarter ended March 31, 2025
- The filing includes Exhibit 99.1 containing the press release of financial results.
Vuzix Corporation filed an 8-K to announce the issuance of a press release containing its financial results for the fiscal period ended December 31, 2024.
📋 Key Facts
- The filing relates to the announcement of financial results for the period ending December 31, 2024.
- The report was filed on March 17, 2025, regarding events occurring on March 13, 2025.
- Financial results were released via a press release attached as Exhibit 99.1.
Vuzix Corporation announced the immediate departure of Chief Operating Officer Peter Jameson on March 11, 2025, citing health reasons. The company has re-aligned senior staff responsibilities to manage the transition.
🚩 Red Flags
- Immediate departure of a key C-suite officer (COO) can create operational uncertainty during transition periods.
📋 Key Facts
- Peter Jameson stepped down as COO effective immediately on March 11, 2025.
- The departure is due to personal health reasons.
- Mr. Jameson had served in the role since January 10, 2022.
- The company has re-aligned and expanded responsibilities among existing senior staff to cover the vacancy.
Vuzix Corporation announced a significant restructuring of executive compensation involving the grant of new Restricted Stock Units (RSUs) to key officers, contingent upon shareholder approval. This plan includes the simultaneous surrender and termination of over 5.3 million previously granted unvested options held by management.
🚩 Red Flags
- Related-party transactions: Significant equity restructuring involving top executives.
- Complexity of compensation: The swap of existing options for new RSUs can be used to reset strike prices or alter incentive structures, often a point of scrutiny for micro-cap investors.
📋 Key Facts
- Granting of 291,878 RSUs to CEO Paul Travers on Jan 2, 2025.
- Granting of 118,211 RSUs to CFO Grant Russell on Jan 2, 2025.
- Granting of 111,642 RSUs to COO Peter Jameson on Jan 2, 2025.
- Aggregate grant of 183,967 RSUs to other management employees.
- Termination of 3,010,000 unvested options for CEO, 1,625,000 for CFO, and 270,000 for COO (all with $19.00 exercise price) upon RSU effectiveness.
- Total surrender/termination of 5,359,500 existing options across all management employees.
- RSU vesting: 50% time-based (3 years); 50% performance-based (up to 125% upside) over 3 years.
- All grants are subject to shareholder approval at the 2025 annual meeting.
Vuzix Corporation filed an 8-K to announce the release of its financial results for the quarterly period ended September 30, 2024. The filing serves as a formal notice that earnings data is being made public via a press release.
📋 Key Facts
- The report covers financial results for the period ended September 30, 2024.
- The information was officially released on November 14, 2024.
- Financial statements are provided in Exhibit 99.1 as a press release.
Vuzix Corporation completed the first tranche of a securities purchase agreement with Quanta Computer Inc. on September 13, 2024. The company issued 7,692,307 shares at $1.30 per share, resulting in $10 million in gross proceeds.
🚩 Red Flags
- Equity dilution for existing shareholders due to the issuance of over 7.6 million new shares.
📋 Key Facts
- Closing date of first tranche: September 13, 2024
- Counterparty: Quanta Computer Inc.
- Shares issued: 7,692,307 shares of common stock
- Price per share: $1.30
- Gross proceeds received: $10 million
Vuzix Corporation entered into a significant securities purchase agreement with Quanta Computer Inc. to raise up to $20 million through the sale of common and Series B Preferred Stock. The deal includes performance-based milestones related to waveguide manufacturing capacity.
🚩 Red Flags
- Significant dilution potential due to the 10-to-1 conversion ratio of Series B Preferred Stock.
- The pricing mechanism for preferred stock (10x VWAP) suggests high volatility or a significant premium/discount structure relative to current common trading price.
- Contingent funding: The full $20M is not guaranteed; it depends on manufacturing production milestones.
📋 Key Facts
- Total potential capital infusion: $20,000,000 ($10M Common, $10M Series B Preferred).
- First closing: $10,000,000 of common stock at $1.30 per share.
- Second and third closings: Two tranches of $5,000,000 in Series B Preferred Stock each.
- Series B pricing: Higher of $13.00 or 10x the 30-day VWAP of common stock.
- Milestones: Subsequent closings are contingent on 'Waveguide Plate Production Capacity Rate' at the Rochester plant meeting specific yields/run-rates.
- Conversion feature: Series B Preferred is convertible into ten shares of common stock per share.
- Dividend: Series B carries a 1.5% cumulative annual dividend payable quarterly.
Vuzix Corporation filed an 8-K to announce the issuance of its financial results for the period ended June 30, 2024. The filing serves as a formal notice that a press release containing these results has been issued.
📋 Key Facts
- The report date is August 14, 2024.
- The company announced financial results for the period ended June 30, 2024.
- Results were released via a press release attached as Exhibit 99.1.
Vuzix Corporation has ceased funding development activities for Atomistic SAS, leading to the termination of a license agreement and an anticipated material impairment charge. The company expects to write down assets totaling up to $32.2 million.
🚩 Red Flags
- Significant material impairment charge ($32.2M) which likely represents a substantial portion of the company's market cap/book value.
- Termination of a strategic technology license agreement.
- Write-down of $5.7 million specifically related to the investment in Atomistic.
📋 Key Facts
- Ceased further funding for development activities with Atomistic SAS under the Dec 16, 2022 License Agreement.
- Atomistic exercised its right to terminate the Granted License on July 1, 2024.
- Anticipated material impairment charge of up to $32.2 million as of July 1, 2024.
- Impairment breakdown: $26.5 million for technology licenses and $5.7 million for investment in Atomistic.
- Vuzix retains an equity interest in Atomistic with a preferential allocation to 49% of distributable amounts in a liquidation event.
- Vuzix retains the right to appoint one member to the Atomistic board of directors.
Vuzix Corporation held its annual meeting of stockholders on June 13, 2024. The results included the election of five directors and the ratification of Freed Maxick, CPAs, P.C. as the independent auditor for 2024.
📋 Key Facts
- Annual meeting held on June 13, 2024.
- Five directors elected: Paul J. Travers, Grant Russell, Edward Kay, Timothy Harned, and Paula Whitten-Doolin.
- Stockholders ratified the appointment of Freed Maxick, CPAs, P.C. as independent registered public accounting firm for 2024.
- Advisory vote on executive officer compensation was approved.
Vuzix Corporation filed an 8-K to announce its financial results for the quarterly period ended March 31, 2024. The filing serves as a formal announcement of the release of their latest earnings press release.
📋 Key Facts
- Report date: May 9, 2024
- Reporting period end date: March 31, 2024
- The company issued a press release (Exhibit 99.1) containing financial results for the quarter.
- Filed under Item 2.02 (Results of Operations and Financial Condition).
Vuzix Corporation filed an 8-K to announce the release of its financial results for the fiscal period ended December 31, 2023. The filing serves as a formal notification that the earnings press release is being issued.
📋 Key Facts
- Report date: April 15, 2024
- Filing date: April 19, 2024
- Reporting period end date: December 31, 2023
- The filing includes Exhibit 99.1 containing the earnings press release.